The long range objective of this project is to develop high resolution MRI into an effective clinical tool for the management of breast cancer. While MRI is unlikely to play a role in general screening for breast cancer, a powerful role may exist for MRI in providing anatomic and biologic staging information that can be used to elucidate problem cases, to stage the extent of disease prior to surgery, to decide treatment strategies and to monitor treatment response. We have a unique opportunity with the collaborative nature of our breast MRI program and a team of breast cancer clinicians and researchers to determine where MRI might play a useful role in the management of breast cancer and to expedite the transition from research to clinical practice. Preliminary results in a subset of patients with primarily late stage breast cancer demonstrate that the high resolution imaging and analysis technique (TARGET) developed by the investigators is highly accurate m anatomic staging and can potentially stratify breast pathologies in-vivo. The first specific aim of this proposal is to determine the diagnostic specificity of TARGET imaging and to extend the evaluation of anatomic and biologic staging accuracy to include a broad spectrum of breast pathologies. The second specific aim will explore TARGET's ability to characterize and distinguish stages in breast disease progression and to measure an early response to therapy in a transgenic mouse model of human breast cancer. The line selected has been shown to develop stochastic, focal tumors in the mammary gland in the presence of a fully functional immune system. This model will provide an opportunity to observe the progression of breast disease with MRI and to investigate the histopathologic basis for changes measured by MRI during therapy. The mice studies will lead to studies using TARGET in clinical trials to evaluate new biotherapies in humans. The third specific aim focuses on technological developments needed in order for breast MRI to be used practically in a clinical setting. These will include image analysis and display capabilities for quick review and assessment of breast MRI data and ultimately for use with a dedicated imaging and breast biopsy magnet system presently under development. As part of the goal to facilitate the translation to clinical usage, a teaching library of cases representing the full spectrum of breast disease, including the normal breast, will be created and made available to breast cancer clinicians and researchers, residents, fellows and faculty. It is expected that this resource will contribute to our increased knowledge and understanding of breast cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA069587-02
Application #
2633919
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Menkens, Anne E
Project Start
1997-01-15
Project End
1999-12-31
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Li, Wen; Arasu, Vignesh; Newitt, David C et al. (2016) Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL. Tomography 2:378-387
Hylton, Nola M; Gatsonis, Constantine A; Rosen, Mark A et al. (2016) Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL. Radiology 279:44-55
McLaughlin, Rebekah L; Newitt, David C; Wilmes, Lisa J et al. (2014) High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging. J Magn Reson Imaging 39:1308-13
Jafri, Nazia F; Newitt, David C; Kornak, John et al. (2014) Optimized breast MRI functional tumor volume as a biomarker of recurrence-free survival following neoadjuvant chemotherapy. J Magn Reson Imaging 40:476-82
Wilmes, Lisa J; McLaughlin, Rebekah L; Newitt, David C et al. (2013) High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response. Acad Radiol 20:581-9
Lehman, Constance D; Blume, Jeffrey D; DeMartini, Wendy B et al. (2013) Accuracy and interpretation time of computer-aided detection among novice and experienced breast MRI readers. AJR Am J Roentgenol 200:W683-9
Jones, Ella F; Sinha, Sumedha P; Newitt, David C et al. (2013) MRI enhancement in stromal tissue surrounding breast tumors: association with recurrence free survival following neoadjuvant chemotherapy. PLoS One 8:e61969
Singer, Lisa; Wilmes, Lisa J; Saritas, Emine U et al. (2012) High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. Acad Radiol 19:526-34
Arasu, Vignesh A; Chen, Ryan C-Y; Newitt, David N et al. (2011) Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions? Acad Radiol 18:716-21
Meyerson, Anna F; Lessing, Juan N; Itakura, Kaoru et al. (2011) Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast 20:529-33

Showing the most recent 10 out of 26 publications